Clinical health psychologist Jamie Ostroff discusses how feelings of blame surrounding a lung cancer diagnosis affect physical and mental health.
by Jen Tota McGivney
A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
by Kate Yandell
Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
Experts discuss the value of cancer treatments in a climate of rising drug prices.
by Kevin McLaughlin
Some researchers believe that immunotherapy occasionally causes cancer to grow faster, a phenomenon dubbed hyper-progression.
Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
FROM THE EDITOR-IN-Chief
Hepatitis C infection, obesity and alcohol can contribute to more cases of liver cancer.
by William G. Nelson, MD, PhD
FORWARD LOOK
Surgery and radiation have similar benefits but different side effects.
by Stephen Ornes
Studies aim to identify when screening is beneficial.
by Sue Rochman
Survivors and advocates display their posters alongside the work of thousands of cancer researchers.
A pair of studies demonstrated encouraging clinical outcomes with two different CAR T-cell therapies for patients with advanced solid tumors.
The U.S. Food and Drug Administration has for the first time approved an immunotherapeutic for breast cancer.
Researchers are studying how to treat EGFR-positive non-small cell lung cancer that has become resistant to tyrosine kinase inhibitors.
A Lesson in Service
donate to the AACR